Trial intelligence / Profile preview

Entecavir vs Lamivudine for HBV Reactivation in NHL

NCT01914744Phase 2Unknown

Sponsor
Fudan University
Start
Feb 2013
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of entecavir in hepatitis B (HBV), sponsored by Fudan University. Status: unknown.

02

Drugs

entecavir
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT01914744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01914744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call